We have previously reported that both Histidine-Tryptophan-Ketoglutarate solution (HTK) and University of Wisconsin solution (UW) provide equal preservation of the pancreas for islet isolation, based upon the assessment of islet yield and function. In this study, we further assessed the ability of each solution to prevent cellular edema. This large-scale, retrospective analysis included the assessment of islet isolation outcomes influenced by cellular edema, such as pancreatic digestion efficacy, purification outcome, and islet size distribution. Multi-variable linear regression analysis, adjusted for donor age, sex, BMI, cold ischemia time, and enzyme, demonstrated similar results for the HTK group (n = 95) and the UW group (n = 157), including post-purification islet yields (the HTK: 289,702 vs. the UW: 283,036; p = 0.76), percentage of digested pancreatic tissue (the HTK: 66.9% vs. the UW: 64.1%; p = 0.18), and islet loss from post-digestion to post-purification (the HTK: 24,972 vs. the UW: 39,551; p = 0.38). Changes in islet size between the post-digestion and post-purification stages were comparable within each islet size category for the HTK and the UW groups (p = 0.14 - 0.99). Tissue volume distribution across purification fractions and islet purity in the top fractions were similar between the groups; however, the HTK group had significantly higher islet purity in the middle fractions (p = 0.003 - 0.008). Islet viability and stimulation indices were also similar between the HTK and the UW groups. In addition, we analyzed a small sample of patients transplanted either with HTK (n = 7) or UW (n = 8) preserved islets and found similar outcomes. This study demonstrates that HTK and UW solutions offer comparable pancreas preservation and are equally efficacious in the prevention of pancreatic tissue edema in islet transplantation. Future studies assessing in vivo islet outcomes in larger samples are needed for complete analysis of the effects of HTK on islet transplantation.